检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

1536P HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+ advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome

J. Tobias, M. Kundi, E. Garner-Spitzer, C. Zielinski, M. Maglakelidze, Z.G. Andric, Z. Petrovic, R. Nagarkar, T. Chawla, L.O. Chong, B. Nixon, S. Yavrom, N. Ede, U. Wiedermann

Annals of Oncology（2023）

引用 0|浏览0
暂无评分
关键词
peptide vaccine,chemotherapy,her-vaxx,dose-dependent,anti-cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要